| human | Q5 |
| P496 | ORCID iD | 0000-0003-0124-4050 |
| P69 | educated at | Indira Gandhi Medical College | Q6024974 |
| P108 | employer | International Agency for Research on Cancer | Q552168 |
| Chittaranjan National Cancer Institute | Q5102433 | ||
| Hammersmith Hospital | Q5645747 | ||
| P734 | family name | Basu | Q56245501 |
| Basu | Q56245501 | ||
| Basu | Q56245501 | ||
| P106 | occupation | researcher | Q1650915 |
| Q104611337 | Acquisition, prevalence and clearance of type-specific human papillomavirus infections in young sexually active Indian women: A community-based multicentric cohort study |
| Q52663358 | Author's reply to: Cancer screening policy in Hungary. |
| Q89254606 | Author's reply to: Implementation and organization of cancer screening in France |
| Q57109555 | Breast Cancer Screening Program in Morocco: Status of implementation, organization and performance |
| Q92866555 | Comparative performance evaluation of different HPV tests and triaging strategies using self-samples and feasibility assessment of thermal ablation in 'colposcopy and treat' approach: A population-based study in rural China |
| Q92213834 | Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to no vaccination or standard three and two-dose vaccination regimens: A systematic review of evidence from clinical trials |
| Q99208291 | Efficacy of Point-of-care Thermal Ablation Among High-risk Human Papillomavirus Positive Women in China |
| Q40556124 | Evaluation of a compact, rechargeable, magnifying device to triage VIA and HPV positive women in a cervical cancer screening program in rural India |
| Q38384071 | HPV detection-based cervical cancer screening program in low-resource setting: lessons learnt from a community-based demonstration project in India |
| Q92305670 | Human papillomavirus (HPV) DNA and mRNA primary cervical cancer screening: Evaluation and triaging options for HPV-positive women |
| Q92866562 | Key issues that need to be considered while revising the current annex of the European Council Recommendation (2003) on cancer screening |
| Q91529819 | Level of human development is associated with cervical cancer stage at diagnosis |
| Q90225797 | Performance indicators in breast cancer screening in the European Union: A comparison across countries of screen positivity and detection rates |
| Q41024539 | Phase 2 Randomized Controlled Trial of Radiation Therapy Plus Concurrent Interferon-Alpha and Retinoic Acid Versus Cisplatin for Stage III Cervical Carcinoma |
| Q113031663 | Risk-Based Selection of Individuals for Oral Cancer Screening |
| Q46964543 | Secondary prevention of cervical cancer |
| Q47937296 | Status of implementation and organization of cancer screening in The European Union Member States-Summary results from the second European screening report. |
| Q64103044 | Study of Knowledge, Attitudes, and Practices Toward Risk Factors and Early Detection of Noncommunicable Diseases Among Rural Women in India |
| Q97428749 | The European response to the WHO call to eliminate cervical cancer as a public health problem |
Search more.